Clinical Outcomes of the Transplantation of Stem Cells from Various Human Tissue Sources in the Management of Liver Cirrhosis: A Systematic Review and Meta-Analysis

被引:27
作者
Qi, Xingshun [1 ]
Guo, Xiaozhong [1 ]
Su, Chunping [2 ]
机构
[1] Gen Hosp Shenyang Mil Area, Dept Gastroenterol, Shenyang, Peoples R China
[2] Lib Fourth Mil Med Univ, Xian, Peoples R China
关键词
Child-Pugh; liver cirrhosis; liver function; MELD; meta analysis; stem cell; treatment; BONE-MARROW-CELLS; SHORT-TERM; AUTOLOGOUS INFUSION; HEPATIC-ARTERY; IMPROVEMENT; MODALITY; FIBROSIS; VARICES; TRIALS;
D O I
10.2174/1574888X09666141112114011
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Aims: A systematic review and meta-analysis were performed to explore the clinical outcome of the transplantation of stem cells from various human tissue sources in cirrhotic patients. Methods: The relevant papers were searched via PubMed, EMBASE, and Cochrane Library databases. Changes in liver function before and after stem cell therapy were evaluated (self-control data). Difference in liver function and incidence of procedure-related complications, hepatocellular carcinoma (HCC), and death between patients undergoing stem cell therapy and conventional treatment were evaluated (case-control data). Results: Of 786 papers initially identified, 31 were included. The sources of stem cell included bone marrow (n=26), umbilical cord (n=3), peripheral blood (n=1), and human fetal liver (n=1). No severe procedure-related complications were reported. According to the meta-analyses of self-control data, model for end-stage liver diseases (MELD) score was significantly reduced at the 3rd-4th and 6th months after stem cell therapy, but this reduction was not statistically significant at the 1st-2nd or 12th postoperative months. Child-Pugh score was also reduced after stem cell therapy, but the reduction was not statistically significant at all follow-up time points. According to the meta-analyses of case-control data, MELD and Child-Pugh scores were not significantly different between treatment and control groups at all follow-up time points. The incidence of HCC was not significantly different between treatment and control groups (odds ratio [OR] to=0.41, P=0.53). The mortality was not significantly different between the two groups (OR=0.48, P=0.20). Conclusion: Stem cell therapy could improve the liver function without any severe procedure-related complications. However, compared with conventional treatment, the benefit of stem cell therapy appeared to be not significant in improving the liver function and survival.
引用
收藏
页码:166 / 180
页数:15
相关论文
共 58 条
  • [11] Current Concepts: Management of Varices and Variceal Hemorrhage in Cirrhosis.
    Garcia-Tsao, Guadalupe
    Bosch, Jaime
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (09) : 823 - 832
  • [12] Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis
    Gasbarrini, A.
    Rapaccini, G. L.
    Rutella, S.
    Zocco, M. A.
    Tittoto, P.
    Leone, G.
    Pola, P.
    Gasbarrini, G.
    Di Campli, C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2007, 39 (09) : 878 - 882
  • [13] [郭学军 Guo Xuejun], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P4367
  • [14] Stem cells as a therapeutic modality in pediatric malformations
    Gupta, D. K.
    Sharma, S.
    Venugopal, P.
    Kumar, L.
    Mohanty, S.
    Dattagupta, S.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) : 700 - 702
  • [15] Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy
    Han, Y.
    Yan, L.
    Han, G.
    Zhou, X.
    Hong, L.
    Yin, Z.
    Zhang, X.
    Wang, S.
    Wang, J.
    Sun, A.
    Liu, Z.
    Xie, H.
    Wu, K.
    Ding, J.
    Fan, D.
    [J]. CYTOTHERAPY, 2008, 10 (04) : 390 - 396
  • [16] [何金秋 He Jinqiu], 2010, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V14, P8521
  • [17] Critical review of clinical trials of bone marrow stem cells in liver disease
    Houlihan, Diarmaid Dominic
    Newsome, Philip Noel
    [J]. GASTROENTEROLOGY, 2008, 135 (02) : 438 - 450
  • [18] Huang Xiao-lun, 2014, Chinese Medical Sciences Journal, V29, P15
  • [19] Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients
    Iwamoto, Takuya
    Terai, Shuji
    Mizunaga, Yuko
    Yamamoto, Naoki
    Omori, Kaoru
    Uchida, Koichi
    Yamasaki, Takahiro
    Fujii, Yasuhiko
    Nishina, Hiroshi
    Sakaida, Isao
    [J]. JOURNAL OF GASTROENTEROLOGY, 2012, 47 (03) : 300 - 312
  • [20] Histological improvement following administration of autologous bone marrow-derived mesenchymal stemcells for alcoholic cirrhosis: a pilot study
    Jang, Yoon Ok
    Kim, Young Ju
    Baik, Soon Koo
    Kim, Moon Young
    Eom, Young Woo
    Cho, Mee Yon
    Park, Hong Jun
    Park, So Yeon
    Kim, Bo Ra
    Kim, Jae Woo
    Kim, Hyun Soo
    Kwon, Sang Ok
    Choi, Eun Hee
    Kim, Yong Man
    [J]. LIVER INTERNATIONAL, 2014, 34 (01) : 33 - 41